Compare DPG & NAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DPG | NAGE |
|---|---|---|
| Founded | N/A | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 535.3M | 507.6M |
| IPO Year | 2011 | N/A |
| Metric | DPG | NAGE |
|---|---|---|
| Price | $14.29 | $4.97 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $16.00 |
| AVG Volume (30 Days) | 107.9K | ★ 1.2M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $20.75 |
| Revenue Next Year | N/A | $19.96 |
| P/E Ratio | ★ N/A | $21.29 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.45 | $4.73 |
| 52 Week High | $14.96 | $14.66 |
| Indicator | DPG | NAGE |
|---|---|---|
| Relative Strength Index (RSI) | 53.21 | 40.54 |
| Support Level | $12.37 | $4.73 |
| Resistance Level | $14.68 | $5.32 |
| Average True Range (ATR) | 0.21 | 0.28 |
| MACD | -0.10 | 0.04 |
| Stochastic Oscillator | 26.14 | 21.04 |
Duff & Phelps Utility & Infrastructure Fund Inc. is an investment fund, and its objective is to seek total return, derived mainly from a high level of current income, with an emphasis on providing tax-advantaged dividend income and growth in current income, and secondarily from capital appreciation.
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.